Home
Conditions
Neonatal Abstinence Syndrome

Clinical trial condition

Neonatal Abstinence Syndrome

Explore clinical trials studying Neonatal Abstinence Syndrome. Study availability and eligibility vary by location and protocol.

51 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Neonatal Abstinence Syndrome trial results

Completed

NAS Treatment - Opiate Versus Non-Opiate

NCT01734551

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: University of Kentucky Medical Center Lexington, Kentucky, United States

View Trial Details

Completed

Vagal Tone and Neonatal Abstinence Syndrome

NCT00496951

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +4 more
Locations: Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States

View Trial Details

Completed

RESPECT-PLUS: Services for Infants With Prenatal Opiate Exposure

NCT02334111

Conditions: Chemically-Induced Disorders, Child Abuse, Child Development, +9 more
Locations: Boston Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Buprenorphine for the Treatment of Neonatal Abstinence Syndrome

NCT00521248

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome

NCT00510016

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: Johns Hopkins Medical Institutions Baltimore, Maryland, United States

View Trial Details

Completed

Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines

NCT01671410

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Conflict Between Maternal Autonomy and Child Health in Substance-use

NCT02797990

Conditions: Alcohol-Related Disorders, Amphetamine-Related Disorders, Chemically-Induced Disorders, +15 more
Locations: Trevor Mann Baby Unit, Royal Sussex County Hospital Brighton, United Kingdom

View Trial Details

Completed

RCT of High- vs. Standard-Calorie Formula for Methadone-Exposed Infants

NCT02178189

Conditions: Body Weight, Body Weight Changes, Chemically-Induced Disorders, +8 more
Locations: Magee-Womens Hospital of UPMC Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

The Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome

NCT01754324

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: The University Hospital Cincinnati, Ohio, United States

Mercy Hospital Anderson Cincinnati, Ohio, United States

View Trial Details

Completed

Treatment of Neonatal Abstinence Syndrome

NCT01723722

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: Eastern Maine Medical Center Bangor, Maine, United States

View Trial Details

Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome trial results

Related conditions